You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple endocrine neoplasia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Retrospective Study for Multiple Endocrine Neoplasia

Recruiting
  • Multiple Endocrine Neoplasia
  • no intervention
  • Taipei, Taiwan
    National Taiwan University Hospital
Apr 2, 2023

Natural History Study of Parathyroid Disorders

Recruiting
  • Parathyroid Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    Studies of Inherited Diseases of Metabolism

    Completed
    • Multiple Endocrine Neoplasia
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 19, 2023

      Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Tumor Trial in Nanning (EUS-guided fine-needle injection)

      Recruiting
      • Multiple Endocrine Neoplasia Type 1
      • Pancreatic Neuroendocrine Tumor
      • EUS-guided fine-needle injection
      • Nanning, Guangxi, China
        First Affiliated Hospital of Guangxi Medical University
      Sep 24, 2022

      Study and Monitoring of Multiple Endocrine Neoplasia Type 1

      Recruiting
      • MEN1
      • Questionnaires
      • Dijon, France
        CHU Dijon Bourgogne
      Jan 4, 2022

      Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 Trial in Utrecht (High-dose-high precision MR-guided

      Recruiting
      • Neuroendocrine Tumor of Pancreas
      • Multiple Endocrine Neoplasia Type 1
      • High-dose-high precision MR-guided radiotherapy
      • Utrecht, Netherlands
        UMC Utrecht
      May 29, 2022

      Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

      Recruiting
      • Advanced Carcinoid Tumor
      • +4 more
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 22, 2022

      Hyperparathyroidism, Hypercalcemia, Parathyroid Tumor Trial run by the NIDDK (68Ga-Dotatate, 18F-DOPA)

      Completed
      Has Results
      • Hyperparathyroidism
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      May 12, 2022

      MEN1 Gene Mutation Trial in Basel (Leflunomide 20 mg)

      Not yet recruiting
      • MEN1 Gene Mutation
      • Leflunomide 20 mg
      • Basel, Switzerland
        Unispital Basel
      Nov 1, 2022

      Familial Investigations of Childhood Cancer Predisposition

      Recruiting
      • Acute Leukemia
      • +45 more
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        May 11, 2022

        Genetic Factors and Pheochromocytomas in Neoplasia Type 2

        Recruiting
        • Neoplasia
        • Pheochromocytoma
          • Marseille, France
            APHM - Hôpital de la Conception
          Jan 30, 2022

          Routine Transcervical Thymectomy in MEN-1 Patients

          Completed
          • Multiple Endocrine Neoplasia Type 1 (MEN-1)
          • Thymic Carcinoid
          • Routine thymectomy, which has been performed
          • Singapore, Singapore
            National University Hospital
          Sep 25, 2021

          Psychosocial Aspects of Multiple Endocrine Neoplasia Syndromes

          Completed
          • Multiple Endocrine Neoplasia
          • Questionnaire
          • Houston, Texas
            University of Texas MD Anderson Cancer Center
          Nov 17, 2020

          Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

          Recruiting
          • Adenocarcinoma
          • +75 more
          • Biomarker Testing (L)
          • +2 more
          • Idaho Falls, Idaho
          • +1 more
          Oct 18, 2022

          Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Type 2A, Multiple Endocrine Neoplasia Type 2B Trial run by the NCI

          Completed
          Has Results
          • Medullary Thyroid Carcinoma
          • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Dec 1, 2020

          Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

          Recruiting
          • Rare Disorders
          • +309 more
            • Sioux Falls, South Dakota
            • +1 more
            Jun 20, 2022

            Meningioma, Metastatic Well Differentiated Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston (Computed

            Terminated
            • Meningioma
            • +5 more
            • Computed Tomography
            • +2 more
            • Houston, Texas
              M D Anderson Cancer Center
            Feb 11, 2021

            Pituitary Tumours: Prevalence of Associated Neoplasia

            Recruiting
            • Pituitary Tumor
            • +4 more
            • Registration of familial forms and associated neoplasia
            • Pozzilli, IS, Italy
              Neuromed
            Aug 31, 2021

            Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Carcinoma Trial in Tampa, Houston (radiation, other, biological)

            Completed
            Has Results
            • Multiple Endocrine Neoplasia Type 1
            • Pancreatic Neuroendocrine Carcinoma
            • Computed Tomography Perfusion Imaging
            • +2 more
            • Tampa, Florida
            • +2 more
            Mar 18, 2020

            Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor, Metastatic Digestive System Neuroendocrine Tumor G1 Trial in

            Completed
            Has Results
            • Gastrin-Producing Neuroendocrine Tumor
            • +10 more
            • Laboratory Biomarker Analysis
            • +2 more
            • Boston, Massachusetts
            • +2 more
            Mar 25, 2020

            d to Developing Multiple Endocrine Neoplasia and Pancreatic

            Recruiting
            • Multiple Endocrine Neoplasia
            • +2 more
            • Genome Sequencing
            • Data Review
            • Houston, Texas
              University of Texas MD Anderson Cancer Center
            Sep 11, 2019

            Trabecular Bone Score in Multiple Sclerosis

            Completed
            • Multiple Sclerosis
            • +2 more
            • sm tbs group
            • Messina, Italy
              IRCCS Centro Neurolesi Bonino Pulejo
            Mar 31, 2023

            Adrenal and Other Endocrine Tumors in Patients With Sudden Death

            Recruiting
            • Primary Aldosteronism
            • +3 more
            • Adrenal aldosterone synthase (CYP11B2) staining
            • +2 more
            • Helsinki, Finland
              Endocrinology, Helsinki University Hospital and University of He
            Jul 8, 2022

            Cervical Intraepithelial Neoplasia Trial (ABI-2280)

            Not yet recruiting
            • Cervical Intraepithelial Neoplasia
            • (no location specified)
            Aug 12, 2022

            Polytrauma Trial in Ostrava (Vitamin D3 + anabolic substance, No Vitamin D3 + anabolic substance)

            Completed
            • Polytrauma
            • Vitamin D3 + anabolic substance
            • No Vitamin D3 + anabolic substance
            • Ostrava, Moravian-Silesian Region, Czechia
              University Hospital Ostrava
            Dec 6, 2022